Data Foundry

Medical device recalls 2017

PENTARAY NAV High-Density Mapping Catheter — Class II medical device recall Z-0212-2018

Terminated recall by Biosense Webster, Inc., reported 2017-12-13, distributed nationwide. Contraindication language updated in the Instructions For Use (IFU) to indicate that Pentaray Catheters should

Recall numberZ-0212-2018
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmBiosense Webster, Inc., Irwindale, CA, United States
Recall initiated2017-05-17
Classified2017-12-07
Reported by FDA2017-12-13
Terminated2020-12-15
DistributedNationwide (US)
Countries outside the USAE, AR, AT, AU, BE, BG, BR, CA, CH, CL, CN, CY, CZ, DE, DK, DZ, EG, ES, FI, FR, GB, GR, HK, HR, HU, ID, IE, IL, IN, IQ, IS, IT, JP, KR, KW, LB, LU, LV, MX, MY, NL, NO, NZ, OM, PL, PT, QA, RO, SA, SE, SG, SI, TH, TR, TW, ZA
Quantity73,796 units
UPC / GTIN / UDI-DI10846835012217, 10846835012224, 10846835012231, 10846835012248, 10846835012255

Product

PENTARAY NAV High-Density Mapping Catheter.

Reason for recall

Contraindication language updated in the Instructions For Use (IFU) to indicate that Pentaray Catheters should not be used in patients with prosthetic valves.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0212-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.